Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism

The (pro)renin receptor [(P)RR] is a multifunctioning protein playing roles in various pathological conditions. A soluble form of (P)RR [s(P)RR] has been considered a biomarker for (P)RR expression in tissues. Expression of (P)RR has been described in aldosterone-producing adenoma (APA), but the rol...

Full description

Saved in:
Bibliographic Details
Main Authors: Daisuke Watanabe, Satoshi Morimoto, Noriko Morishima, Yoichiro Kato, Yoji Nagashima, Noriyuki Shibata, Atsuhiro Ichihara
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2020/9640103
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552563325534208
author Daisuke Watanabe
Satoshi Morimoto
Noriko Morishima
Yoichiro Kato
Yoji Nagashima
Noriyuki Shibata
Atsuhiro Ichihara
author_facet Daisuke Watanabe
Satoshi Morimoto
Noriko Morishima
Yoichiro Kato
Yoji Nagashima
Noriyuki Shibata
Atsuhiro Ichihara
author_sort Daisuke Watanabe
collection DOAJ
description The (pro)renin receptor [(P)RR] is a multifunctioning protein playing roles in various pathological conditions. A soluble form of (P)RR [s(P)RR] has been considered a biomarker for (P)RR expression in tissues. Expression of (P)RR has been described in aldosterone-producing adenoma (APA), but the roles of (P)RR have yet to be fully determined. This study investigated the significance of (P)RR and serum s(P)RR concentrations in patients with APA. We evaluated associations between (P)RR expression and expression of CYP11B2, an aldosterone synthase, and aldosterone production by the adrenal glands and assessed the relationships between serum s(P)RR concentration and background factors. (P)RR colocalized with CYP11B2 and expression levels of (P)RR were positively associated with those of CYP11B2 in APA tissues. (P)RR immunoreactivity in these tissues correlated positively with plasma aldosterone concentrations (PAC) and urinary aldosterone excretion. Also, in APA, (P)RR mRNA abundance was positively correlated with β-catenin mRNA abundance. Significant positive correlations were identified between serum s(P)RR concentration and plasma glucose, hemoglobin A1c, and serum creatinine levels, but not with PAC (in either peripheral vein or adrenal vein) or adrenal (P)RR expression level. This study showed that (P)RR expression level correlates with CYP11B2 expression in APA tissues and PAC and urinary aldosterone excretion, suggesting that (P)RR expression may contribute to aldosterone synthesis via CYP11B2 activation in APAs, although serum s(P)RR concentration failed to show any significant relationship with adrenal (P)RR expression. Adrenal (P)RR activity might offer a therapeutic target in the treatment of PA, although this issue needs to be investigated in future studies.
format Article
id doaj-art-56a239b6e2ce4786a89c00372d11175a
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-56a239b6e2ce4786a89c00372d11175a2025-02-03T05:58:22ZengWileyInternational Journal of Endocrinology1687-83371687-83452020-01-01202010.1155/2020/96401039640103Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary AldosteronismDaisuke Watanabe0Satoshi Morimoto1Noriko Morishima2Yoichiro Kato3Yoji Nagashima4Noriyuki Shibata5Atsuhiro Ichihara6Department of Endocrinology and Hypertension, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, JapanDepartment of Endocrinology and Hypertension, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, JapanDepartment of Endocrinology and Hypertension, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, JapanDepartment of Pathology, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, JapanDepartment of Surgical Pathology, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, JapanDepartment of Pathology, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, JapanDepartment of Endocrinology and Hypertension, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo 162-8666, JapanThe (pro)renin receptor [(P)RR] is a multifunctioning protein playing roles in various pathological conditions. A soluble form of (P)RR [s(P)RR] has been considered a biomarker for (P)RR expression in tissues. Expression of (P)RR has been described in aldosterone-producing adenoma (APA), but the roles of (P)RR have yet to be fully determined. This study investigated the significance of (P)RR and serum s(P)RR concentrations in patients with APA. We evaluated associations between (P)RR expression and expression of CYP11B2, an aldosterone synthase, and aldosterone production by the adrenal glands and assessed the relationships between serum s(P)RR concentration and background factors. (P)RR colocalized with CYP11B2 and expression levels of (P)RR were positively associated with those of CYP11B2 in APA tissues. (P)RR immunoreactivity in these tissues correlated positively with plasma aldosterone concentrations (PAC) and urinary aldosterone excretion. Also, in APA, (P)RR mRNA abundance was positively correlated with β-catenin mRNA abundance. Significant positive correlations were identified between serum s(P)RR concentration and plasma glucose, hemoglobin A1c, and serum creatinine levels, but not with PAC (in either peripheral vein or adrenal vein) or adrenal (P)RR expression level. This study showed that (P)RR expression level correlates with CYP11B2 expression in APA tissues and PAC and urinary aldosterone excretion, suggesting that (P)RR expression may contribute to aldosterone synthesis via CYP11B2 activation in APAs, although serum s(P)RR concentration failed to show any significant relationship with adrenal (P)RR expression. Adrenal (P)RR activity might offer a therapeutic target in the treatment of PA, although this issue needs to be investigated in future studies.http://dx.doi.org/10.1155/2020/9640103
spellingShingle Daisuke Watanabe
Satoshi Morimoto
Noriko Morishima
Yoichiro Kato
Yoji Nagashima
Noriyuki Shibata
Atsuhiro Ichihara
Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
International Journal of Endocrinology
title Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
title_full Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
title_fullStr Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
title_full_unstemmed Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
title_short Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism
title_sort adrenal pro renin receptor expression and serum soluble pro renin receptor concentration in primary aldosteronism
url http://dx.doi.org/10.1155/2020/9640103
work_keys_str_mv AT daisukewatanabe adrenalproreninreceptorexpressionandserumsolubleproreninreceptorconcentrationinprimaryaldosteronism
AT satoshimorimoto adrenalproreninreceptorexpressionandserumsolubleproreninreceptorconcentrationinprimaryaldosteronism
AT norikomorishima adrenalproreninreceptorexpressionandserumsolubleproreninreceptorconcentrationinprimaryaldosteronism
AT yoichirokato adrenalproreninreceptorexpressionandserumsolubleproreninreceptorconcentrationinprimaryaldosteronism
AT yojinagashima adrenalproreninreceptorexpressionandserumsolubleproreninreceptorconcentrationinprimaryaldosteronism
AT noriyukishibata adrenalproreninreceptorexpressionandserumsolubleproreninreceptorconcentrationinprimaryaldosteronism
AT atsuhiroichihara adrenalproreninreceptorexpressionandserumsolubleproreninreceptorconcentrationinprimaryaldosteronism